Arcadia Dialysis Center in Arcadia, Florida - Dialysis Center

Arcadia Dialysis Center is a medicare approved dialysis facility center in Arcadia, Florida and it has 16 dialysis stations. It is located in De Soto county at 1341 E Oak St, Arcadia, FL, 34266. You can reach out to the office of Arcadia Dialysis Center at (863) 491-8550. This dialysis clinic is managed and/or owned by Davita. Arcadia Dialysis Center has the following ownership type - Profit. It was first certified by medicare in July, 1999. The medicare id for this facility is 102757 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameArcadia Dialysis Center
Location1341 E Oak St, Arcadia, Florida
No. of Dialysis Stations 16
Medicare ID102757
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


1341 E Oak St, Arcadia, Florida, 34266
(863) 491-8550
Not Available

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Arcadia Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1093782658
Organization NameArcadia Dialysis Center
Doing Business AsTotal Renal Care Inc
Address1341 E Oak St Arcadia, Florida, 34266
Phone Number(863) 491-8550

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data39

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center66
    Adult patient months included in Kt/V greater than or equal to 1.2570
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

    Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

    WellCare reports GAAP net income of $6.4 million for first-quarter 2010

    WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

    MRI techniques can measure changes in microstructural properties of white matter

    Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

    Pelvic imaging using CT exams are not necessary for VTE diagnosis

    A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

    Pfizer's Prevenar 13 gets US approval for adults

    Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Arcadia Dialysis Center with elevated calcium levels.

Patients with hypercalcemia67
Hypercalcemia patient months580
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor72
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 58
Patient months included in arterial venous fistula and catheter summaries 512
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Impax Laboratories receives FDA notice regarding Hayward manufacturing facility

Impax Laboratories, Inc. today announced that it received written notice from the United States Food and Drug Administration verifying that the Company has successfully addressed all items raised by the FDA in the May 2011 Warning Letter relating to its Hayward, California manufacturing facility.

WellCare reports GAAP net income of $6.4 million for first-quarter 2010

WellCare Health Plans, Inc. today reported results for the first quarter ended March 31, 2010. As determined under generally accepted accounting principles, the Company reported net income of $6.4 million, or $0.15 per diluted share, compared with a net loss of $36.9 million, or $0.89 per diluted share, for the prior year period. Adjusted net income for the first quarter of 2010 was $7.4 million, or $0.17 per diluted share, as compared with $12.3 million, or $0.29 per diluted share, for the same period in 2009.

MRI techniques can measure changes in microstructural properties of white matter

Innovative magnetic resonance imaging (MRI) techniques that can measure changes in the microstructure of the white matter likely to affect brain function and the ability of different regions of the brain to communicate are presented in an article in the groundbreaking new neuroscience journal Brain Connectivity, a bimonthly peer-reviewed publication from Mary Ann Liebert, Inc.

Pelvic imaging using CT exams are not necessary for VTE diagnosis

A recent study shows that pelvic imaging using computed tomography examinations are not necessary for diagnosing patients with venous thromboembolism and eliminating this exam can significantly reduce a patient's exposure to excessive radiation dose.

Pfizer's Prevenar 13 gets US approval for adults

Health authorities of United States have approved the expansion of Pfizer Inc's Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. The vaccine, which had been approved for children in the United States, is already one of Pfizer's biggest brands and an expanded population of adults could generate more than $1.5 billion in annual sales.

Read more Medical News

› Verified 5 days ago